FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080528069> ?p ?o ?g. }

• W3080528069 endingPage "100860" @default.
• W3080528069 startingPage "100860" @default.
• W3080528069 abstract "The high mortality rate from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in humans and the lack of effective therapeutic regime for its treatment necessitates the identification of new antivirals. SARS-CoV-2 relies on non-structural proteins such as Nsp13 helicase and nsp14 which are the key components of the replication-transcription complex (RTC) to complete its infectious life cycle. Therefore, targeting these essential viral proteins with small molecules will most likely to halt the disease pathogenesis. The lack of experimental structures of these proteins deters the process of structure-based identification of their specific inhibitors. In the present study, the in silico models of SARS-CoV-2 nsp13 helicase and nsp14 protein were elucidated using a comparative homology modelling approach. These in silico model structures were validated using various parameters such as Ramachandran plot, Verify 3D score, ERRAT score, knowledge-based energy and Z-score. The in silico models were further used for virtual screening of the Food and Drug Administration (FDA) approved antiviral drugs. Simeprevir (SMV), Paritaprevir (PTV) and Grazoprevir (GZR) were the common leads identified which show higher binding affinity to both nsp13 helicase and nsp14 as compared to the control inhibitors and therefore, they might be potential dual-target inhibitors. The leads also establish a network of hydrogen bonds and hydrophobic interactions with the key residues lining the active site pockets. The present findings suggest that these FDA approved antiviral drugs can be subjected to repurposing against SARS-CoV-2 infection after verifying the in silico results through in vitro and in vivo studies." @default.
• W3080528069 created "2020-09-01" @default.
• W3080528069 creator A5016283313 @default.
• W3080528069 date "2020-12-01" @default.
• W3080528069 modified "2023-09-26" @default.
• W3080528069 title "In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors" @default.
• W3080528069 cites W1595347157 @default.
• W3080528069 cites W1607931568 @default.
• W3080528069 cites W1863266496 @default.
• W3080528069 cites W1965280032 @default.
• W3080528069 cites W1965669216 @default.
• W3080528069 cites W1975304761 @default.
• W3080528069 cites W1980892321 @default.
• W3080528069 cites W1995042237 @default.
• W3080528069 cites W2001139474 @default.
• W3080528069 cites W2003116453 @default.
• W3080528069 cites W2015642465 @default.
• W3080528069 cites W2020629025 @default.
• W3080528069 cites W2031300259 @default.
• W3080528069 cites W2037978116 @default.
• W3080528069 cites W2059763393 @default.
• W3080528069 cites W2066018734 @default.
• W3080528069 cites W2074473216 @default.
• W3080528069 cites W2078510009 @default.
• W3080528069 cites W2095450147 @default.
• W3080528069 cites W2105668062 @default.
• W3080528069 cites W2106154817 @default.
• W3080528069 cites W2108226298 @default.
• W3080528069 cites W2112898697 @default.
• W3080528069 cites W2132629607 @default.
• W3080528069 cites W2147421370 @default.
• W3080528069 cites W2148979869 @default.
• W3080528069 cites W2152770371 @default.
• W3080528069 cites W2169198329 @default.
• W3080528069 cites W2169678694 @default.
• W3080528069 cites W2171291163 @default.
• W3080528069 cites W2177317049 @default.
• W3080528069 cites W2306812407 @default.
• W3080528069 cites W2318325277 @default.
• W3080528069 cites W2410066853 @default.
• W3080528069 cites W2560620646 @default.
• W3080528069 cites W2733796536 @default.
• W3080528069 cites W2947817007 @default.
• W3080528069 cites W3001118548 @default.
• W3080528069 cites W3008142620 @default.
• W3080528069 cites W3010699833 @default.
• W3080528069 cites W3010880616 @default.
• W3080528069 cites W3021826725 @default.
• W3080528069 cites W3034228022 @default.
• W3080528069 cites W3049051510 @default.
• W3080528069 cites W4245774281 @default.
• W3080528069 doi "https://doi.org/10.1016/j.genrep.2020.100860" @default.
• W3080528069 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7452913" @default.
• W3080528069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32875166" @default.
• W3080528069 hasPublicationYear "2020" @default.
• W3080528069 type Work @default.
• W3080528069 sameAs 3080528069 @default.
• W3080528069 citedByCount "48" @default.
• W3080528069 countsByYear W30805280692020 @default.
• W3080528069 countsByYear W30805280692021 @default.
• W3080528069 countsByYear W30805280692022 @default.
• W3080528069 countsByYear W30805280692023 @default.
• W3080528069 crossrefType "journal-article" @default.
• W3080528069 hasAuthorship W3080528069A5016283313 @default.
• W3080528069 hasBestOaLocation W30805280691 @default.
• W3080528069 hasConcept C103637391 @default.
• W3080528069 hasConcept C103697762 @default.
• W3080528069 hasConcept C104317684 @default.
• W3080528069 hasConcept C140704245 @default.
• W3080528069 hasConcept C14301744 @default.
• W3080528069 hasConcept C159047783 @default.
• W3080528069 hasConcept C161223559 @default.
• W3080528069 hasConcept C2522874641 @default.
• W3080528069 hasConcept C2775905019 @default.
• W3080528069 hasConcept C2780035454 @default.
• W3080528069 hasConcept C47701112 @default.
• W3080528069 hasConcept C54355233 @default.
• W3080528069 hasConcept C55493867 @default.
• W3080528069 hasConcept C60644358 @default.
• W3080528069 hasConcept C67705224 @default.
• W3080528069 hasConcept C70721500 @default.
• W3080528069 hasConcept C74187038 @default.
• W3080528069 hasConcept C86803240 @default.
• W3080528069 hasConcept C98274493 @default.
• W3080528069 hasConceptScore W3080528069C103637391 @default.
• W3080528069 hasConceptScore W3080528069C103697762 @default.
• W3080528069 hasConceptScore W3080528069C104317684 @default.
• W3080528069 hasConceptScore W3080528069C140704245 @default.
• W3080528069 hasConceptScore W3080528069C14301744 @default.
• W3080528069 hasConceptScore W3080528069C159047783 @default.
• W3080528069 hasConceptScore W3080528069C161223559 @default.
• W3080528069 hasConceptScore W3080528069C2522874641 @default.
• W3080528069 hasConceptScore W3080528069C2775905019 @default.
• W3080528069 hasConceptScore W3080528069C2780035454 @default.
• W3080528069 hasConceptScore W3080528069C47701112 @default.
• W3080528069 hasConceptScore W3080528069C54355233 @default.
• W3080528069 hasConceptScore W3080528069C55493867 @default.
• W3080528069 hasConceptScore W3080528069C60644358 @default.

• next